According to this new meta-analysis (presented at AHA 2021 and published in The Lancet), mortality is similar between surgery and angioplasty to treat left main coronary artery in patients with simple or intermediate anatomy. This new study estimates that, after 5 years, mortality with surgery would be 11.2% vs. 10.2% with angioplasty, a non-significant difference. This debate...
No decision on the coronary tree has more impact than left main intervention. This makes interventionists prone to over and underestimation of angiographic imaging. In other words, in real life we never report on angiograms showing moderate left main lesions. This reality should be looked into, since operating or intervening moderate left main lesions on...
Treating the left main coronary artery with provisional stenting was non-inferior to systematic dual stenting in the EBC MAIN trial, presented at EuroPCR 2021 and simultaneously published in the European Heart Journal. The composite primary endpoint of death, infarction, and target-lesion revascularization was 14.7% for provisional stenting vs. 17.7% for systematic dual stenting (hazard ratio:...
Watch again our Webinar on “Left Main PCI and Bifurcations: LATAM Bif Registry” on our Youtube account. The event was held on March 3rd, 2021, and had the participation of almost 700 people and the support of ABBOTT, Boston Scientific, Medtronic and Terumo. Webinar Contents 00:02 | Introduction – Dr. José Mangione (BRA). 04:58 |...
We invite you to participate in the first free SOLACI virtual event of 2021. It is carried out with the support of Abbott, Boston Scientific, Medtronic and Terumo Interventional Systems and will have the participation of prestigious hemodynamicists from Latin America and the world. The title of the event is: “Left Main PCI and Bifurcations:...
Watch again our Webinar on “Left Main Coronary Disease Controversy After EXCEL 5 Years” on our Youtube account. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Courtesy of Dr. Carlos Fava. Unprotected left main PCI (PCI-UPLMS) is an acceptable and comparable strategy vs CABG, although the use of IVUS is advisable, since it has shown better evolution and mortality. However, the adequate stent expansion remains unclear. Researchers carried out a sub-analyzis of the NOBLE trial. Of the total 603 patients receiving...
Deferral of left main coronary artery lesions using instantaneous wave-free ratio (iFR) seems to be safe. At the least, patients with deferred lesions had similar long-term prognosis to that of patients who underwent revascularization based on that same indicator. Left main coronary artery lesions were universally excluded from studies including medical treatment among the therapeutic...
Check out our Webinar on “Left Main Coronary Artery PCI 360°: Clinical Case, Technique and Evidence” on our Youtube account. The event was promoted by the areas of ProEducar, SOLACI Research and SOLACI Sessions, and included the participation of prominent Latin American interventionists. In addition, a complex clinical case was presented on Left Main PCI...
We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.